Chemoinformaics analysis of 1-Methoxy-2-methylanthracene-9,10-dione
| Molecular Weight | 252.269 | nRot | 1 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 32 |
| Exact Molecular Weight | 252.079 | nRing | 3 |
| Solubility: LogS | -4.65 | nHRing | 0 |
| Solubility: LogP | 3.243 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 37.1275 |
| nHD | 0 | BPOL | 15.5105 |
| QED | 0.267 |
| Synth | 6.71 |
| Natural Product Likeliness | 2.827 |
| NR-PPAR-gamma | 0.63 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.014 |
| HIA | 0.046 |
| CACO-2 | -5.207 |
| MDCK | 0.0000718 |
| BBB | 0.796 |
| PPB | 0.791733 |
| VDSS | 1.971 |
| FU | 0.198478 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.099 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.355 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.032 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.104 |
| CYP3a4-inh | 0.599 |
| CYP3a4-sub | 0.587 |
| CL | 14.446 |
| T12 | 0.034 |
| hERG | 0.036 |
| Ames | 0.016 |
| ROA | 0.988 |
| SkinSen | 0.015 |
| Carcinogencity | 0.048 |
| EI | 0.02 |
| Respiratory | 0.979 |
| NR-Aromatase | 0.036 |
| Antiviral | Yes |
| Prediction | 0.747961 |